In liver aging studies, the preparation reduced lipid peroxidation damage, improved detoxification function, inhibited liver fibrosis, and ameliorated aging-related pathological changes
Ready to Feel the Difference
However, these findings were derived from heterogeneous models with inconsistent dosing regimens and variable outcome definitions (Cerovecki et al
Handle all reconstitution materials under sterile conditions and use appropriate PPE throughout the procedure
The concern is cumulative time outside refrigeration
Oral or troche dose: Determined at APRN intake based on your GI indication and treatment goal Troche format: Held sublingually for 60 to 90 seconds before swallowing for improved absorption Best use case: GI inflammation, IBS, gut lining repair, Crohns management, systemic anti-inflammatory support Not optimal for: Localized tendon, joint, or muscle injury where injection near the site is more targeted Injury vs Gut Protocol: See What Dosing Looks Like for Your Use Case BPC-157 dosage differs by indication